Cancer risk-reducing surgery: Brazilian Society of Surgical Oncology Guideline Part 2 (Gastrointestinal and thyroid)

被引：0

作者：

Carneiro, Vandre C. G. ^{[1
,2
,3
]}

Gifoni, Ana C. L. V. C. ^{[3
]}

Rossi, Benedito M. ^{[4
]}

da Cunha Andrade, Carlos E. M. ^{[5
]}

de Lima, Fernanda T. ^{[6
,7
]}

Reis Galvao, Henrique de Campos ^{[8
]}

da Rocha, Jose C. C. ^{[9
]}

da Silva Barreto, Leonardo S. ^{[10
]}

Ashton-Prolla, Patricia ^{[11
]}

Guindalini, Rodrigo S. C. ^{[3
]}

de Farias, Terence P. ^{[12
]}

Andrade, Wesley P. ^{[13
,14
,15
]}

de Sousa Fernandes, Paulo H. ^{[16
]}

Ribeiro, Reitan ^{[17
]}

Lopes, Andre ^{[18
]}

Tsunoda, Audrey T. ^{[17
,19
]}

Azevedo, Bruno R. B. ^{[20
,21
]}

Marins, Carlos A. M. ^{[12
,22
]}

de Albuquerque Oliveira Uchoa, Diego N. ^{[23
]}

Dos Santos, Evandro A. S. ^{[24
]}

Coimbra, Felipe J. F. ^{[9
]}

Francisco, A. D. Filho ^{[25
]}

de Oliveira Lopes, Francisco C. ^{[26
]}

Fernandes, Francisco G. ^{[27
]}

Ritt, Guilherme F. ^{[28
]}

Laporte, Gustavo A. ^{[29
]}

Guimaraes, Gustavo C. ^{[13
]}

Castro Neto, Heladio Feitosa E. ^{[30
]}

dos Santos, Jocela C. ^{[31
]}

de Carvalho Vilela, Jordana B. ^{[32
]}

Jorge, G. M. Junior ^{[29
,33
]}

da Cunha, Juliano R. ^{[16
]}

Milhomem, Leonardo M. ^{[34
]}

da Silva, Luciana M. ^{[2
]}

Maciel, Luiza de Freitas ^{[12
]}

Ramalho, Nathalia M. ^{[1
,3
]}

Nunes, Rafael L. ^{[35
]}

de Araujo, Rodrigo G. ^{[2
]}

Ehrhardt, Rogerio de Assuncao ^{[2
]}

Bocanegra, Ronald E. D. ^{[36
]}

Tyrone, C. S. Junior ^{[37
]}

de Oliveira, Viviane R. ^{[38
]}

Surima, Walyson S. ^{[39
]}

Melquiades, Miriam de Melo ^{[40
]}

de Castro Ribeiro, Heber S. ^{[9
,41
]}

Oliveira, Alexandre F. ^{[41
,42
]}

机构：

[1] Inst Med Integral Prof Fernando Figueira, Dept Surg, Oncol, Gynecol, Recife, PE, Brazil

[2] Hosp Canc Pernambuco, Dept Pelv Surg, Hereditary Canc Program, Recife, PE, Brazil

[3] Oncol Dor, Dept Oncogenet, Oncol, Rio De Janeiro, Brazil

[4] Hosp Sirio Libanes, Dept Oncogenet, Surg Oncol, Sao Paulo, Brazil

[5] Barretos Canc Hosp, Dept Oncogynecol, Barretos, Brazil

[6] Hosp Israelita Albert Einstein, Dept Oncogenet, Sao Paulo, Brazil

[7] UNIFESP EPM, Dept Oncogenet, Sao Paulo, Brazil

[8] DASA, Dept Oncogenet, Sao Paulo, Brazil

[9] AC Camargo Canc Ctr, Dept Oncogenet, Abdominal Surg, Sao Paulo, Brazil

[10] HUOL UFRN, Dept Surg, Natal, RN, Brazil

[11] Univ Fed Rio Grande do Sul, Dept Genet, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil

[12] INCA, Dept Head & Neck, Oncol Surg, Rio De Janeiro, Brazil

[13] Hosp Beneficencia Portuguesa, Dept Surg, Sao Paulo, Brazil

[14] Hosp Oswaldo Cruz, Dept Surg, Sao Paulo, Brazil

[15] Hosp Santa Catarina, Dept Surg, Sao Paulo, Brazil

[16] Univ Fed Uberlandia, Dept Surg, Uberlandia, MG, Brazil

[17] Hosp Erasto Gaertner, Dept Surg Oncol, Curitiba, Parana, Brazil

[18] Sao Camilo Oncol, Dept Surg Oncol, Sao Paulo, Brazil

[19] Pontificia Univ Catolica Parana, Dept Surg, Curitiba, Parana, Brazil

[20] Oncoclinicas, Dept Surg Oncol, Curitiba, Parana, Brazil

[21] Pilar Hosp, Dept Surg, Curitiba, Parana, Brazil

[22] Hosp Fed Serv Estado, Dept Surg, Rio De Janeiro, Brazil

[23] Hosp Univ Prof Alberto Antunes UFAL, Dept Surg, Maceio, Brazil

[24] IMERV, Dept Surg, Ribeirao Preto, Brazil

[25] Hosp Reg Cacoal, Dept Surg, Cacoal, Brazil

[26] Hosp Coracao Londrina, Dept Surg, Londrina, Parana, Brazil

[27] Hosp Canc UOPECCAN, Dept Surg Oncol, Cascavel, Brazil

[28] AMO OSID, Dept Surg, Salvador, BA, Brazil

[29] Santa Casa de Misericordia Porto Alegre, Dept Surg, Porto Alegre, RS, Brazil

[30] Inst Canc Ceara, Dept Surg Oncol, Fortaleza, Ceara, Brazil

[31] HUPAA UFAL, Dept Surg, Maceio, Brazil

[32] Hosp Canc Araujo Jorge, Dept Surg Oncol, Goiania, Go, Brazil

[33] Hosp Santa Rita, Dept Surg, Porto Alegre, RS, Brazil

[34] Univ Fed Goias, Dept Surg, Hosp Clin, Goiania, Go, Brazil

[35] GNDI Notredame Intermed Hosp Salvalus, Dept Surg, Sao Paulo, Brazil

[36] Santa Casa de Misericordia Bahia, Dept Surg, Salvador, BA, Brazil

[37] Real Hosp Portugues Pernambuco, Dept Surg, Recife, PE, Brazil

[38] Hosp Univ Brasilia, Dept Surg, Brasilia, DF, Brazil

[39] Hosp Geral Fortaleza, Dept Surg, Fortaleza, Ceara, Brazil

[40] Hosp Albert Sabin, Dept Oncogenet, Juiz De Fora, Brazil

[41] SBCO, Rio De Janeiro, Brazil

[42] Univ Fed Juiz de Fora, Dept Surg, Juiz De Fora, Brazil

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2022年 / 126卷 / 01期

关键词：

colon cancer; gastric cancer; practice guideline; surgery; thyroid cancer; DIFFUSE GASTRIC-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; NEOPLASIA TYPE 2B; RET PROTOONCOGENE; CODON; 883; MUTATION; CARCINOMA; SURVEILLANCE; PHENOTYPE; GENOTYPE;

D O I：

10.1002/jso.26813

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background Risk-reducing operations are an important part of the management of hereditary predisposition to cancer. In selected cases, they can considerably reduce the morbidity and mortality associated with cancer in this population. Objectives The Brazilian Society of Surgical Oncology (BSSO) developed this guideline to establish national benchmarks for cancer risk-reducing operations. Methods The guideline was prepared from May to December 2021 by a multidisciplinary team of experts to discuss the surgical management of cancer predisposition syndromes. Eleven questions were defined and assigned to expert groups that reviewed the literature and drafted preliminary recommendations. Following a review by the coordinators and a second review by all participants, the groups made final adjustments, classified the level of evidence, and voted on the recommendations. Results For all questions including risk-reducing colectomy, gastrectomy, and thyroidectomy, a major agreement was achieved by the participants, always using accessible alternatives. Conclusion This and its accompanying article represent the first guideline in cancer risk reduction surgery developed by the BSSO and it should serve as an important reference for the management of families with cancer predisposition.

引用

页码：20 / 27

页数：8

共 42 条

[1] Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update [J].

Aihara, Hiroyuki ;

Kumar, Nitin ;

Thompson, Christopher C. .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (03) :255-262

[2] The Differential Diagnosis and Surveillance of Hereditary Gastrointestinal Polyposis Syndromes [J].

Aretz, Stefan .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (10) :163-U16

[3] Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis [J].

Bertario, L ;

Russo, A ;

Radice, P ;

Varesco, L ;

Eboli, M ;

Spinelli, P ;

Reyna, A ;

Sala, P .

ANNALS OF SURGERY, 2000, 231 (04) :538-543

[4]

Blair VR, 2020, LANCET ONCOL, V21, pE386, DOI 10.1016/S1470-2045(20)30219-9

[5] SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B [J].

CARLSON, KM ;

DOU, SS ;

CHI, D ;

SCAVARDA, N ;

TOSHIMA, K ;

JACKSON, CE ;

WELLS, SA ;

GOODFELLOW, PJ ;

DONISKELLER, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1579-1583

[6] In which patients do I perform IRA, and why? [J].

Church, James .

FAMILIAL CANCER, 2006, 5 (03) :237-240

[7] Controversies in the surgery of patients with familial adenomatous polyposis and Lynch syndrome [J].

Church, James M. .

FAMILIAL CANCER, 2016, 15 (03) :447-451

[8] Olaparib for Metastatic Castration-Resistant Prostate Cancer [J].

de Bono, J. ;

Mateo, J. ;

Fizazi, K. ;

Saad, F. ;

Shore, N. ;

Sandhu, S. ;

Chi, K. N. ;

Sartor, O. ;

Agarwal, N. ;

Olmos, D. ;

Thiery-Vuillemin, A. ;

Twardowski, P. ;

Mehra, N. ;

Goessl, C. ;

Kang, J. ;

Burgents, J. ;

Wu, W. ;

Kohlmann, A. ;

Adelman, C. A. ;

Hussain, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2091-2102

[9] Genotype-phenotype correlation in 99 familial adenomatous polyposis patients: A prospective prevention protocol [J].

de Oliveira, Junea C. ;

Viana, Danilo V. ;

Zanardo, Cleyton ;

Santos, Erika M. M. ;

de Paula, Andre E. ;

Palmero, Edenir, I ;

Rossi, Benedito M. .

CANCER MEDICINE, 2019, 8 (05) :2114-2122

[10] Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report [J].

Dominguez-Valentin, Mev ;

Seppala, Toni T. ;

Sampson, Julian R. ;

Macrae, Finlay ;

Winship, Ingrid ;

Evans, D. Gareth ;

Scott, Rodney J. ;

Burn, John ;

Moeslein, Gabriela ;

Bernstein, Inge ;

Pylvanainen, Kirsi ;

Renkonen-Sinisalo, Laura ;

Lepistoe, Anna ;

Lindblom, Annika ;

Plazzer, John-Paul ;

Tjandra, Douglas ;

Thomas, Huw ;

Green, Kate ;

Lalloo, Fiona ;

Crosbie, Emma J. ;

Hill, James ;

Capella, Gabriel ;

Pineda, Marta ;

Navarro, Matilde ;

Vidal, Joan Brunet ;

Ronlund, Karina ;

Nielsen, Randi Thyregaard ;

Yilmaz, Mette ;

Elvang, Louise Laurberg ;

Katz, Lior ;

Nielsen, Maartje ;

ten Broeke, Sanne W. ;

Nakken, Sigve ;

Hovig, Eivind ;

Sunde, Lone ;

Kloor, Matthias ;

Doeberitz, Magnus von Knebel ;

Ahadova, Aysel ;

Lindor, Noralane ;

Steinke-Lange, Verena ;

Holinski-Feder, Elke ;

Mecklin, Jukka-Pekka ;

Moller, Pal .

HEREDITARY CANCER IN CLINICAL PRACTICE, 2019, 17 (01)

← 1 2 3 4 5 →